Ambulatory oxygen in fibrotic lung disease (AmbOx): Study protocol for a randomised controlled trial

Trials

Volumn 18, Issue 1, 2017, Pages

  Visca, Dina ^a   Tsipouri, Vicky ^a   Mori, Letizia ^a   Firouzi, Ashi ^a   Fleming, Sharon ^a   Farquhar, Morag ^b   Leung, Elizabeth ^a   Maher, Toby M ^a   Cullinan, Paul ^a   Hopkinson, Nick ^a   Wells, Athol U ^a   Banya, Winston ^a   Whitty, Jennifer A ^c   Adamali, Huzaifa ^d   Spencer, Lisa G ^e   Sestini, Piersante ^f   Renzoni, Elisabetta A ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^f UNIVERSITY OF SIENA   (Italy)

Author keywords

Activity measures; Ambulatory oxygen; Fibrotic interstitial lung disease; Health status; Oxygen desaturation; Quality of life; Shortness of breath

Indexed keywords

ACETYLCYSTEINE; ANTIFIBROTIC AGENT; BRAIN NATRIURETIC PEPTIDE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; OXYGEN; PLACEBO; BIOLOGICAL MARKER;

AMBULATORY CARE; ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; CROSSOVER PROCEDURE; DYSPNEA; HEALTH ECONOMICS; HEALTH STATUS; HOME OXYGEN THERAPY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OXYGEN DESATURATION; OXYGEN SATURATION; OXYGEN THERAPY; PROSPECTIVE STUDY; PULSE OXIMETRY; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL; SAFETY; SEMI STRUCTURED INTERVIEW; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; THERAPY EFFECT; BLOOD; CLINICAL PROTOCOL; CLINICAL TRIAL; DAILY LIFE ACTIVITY; FIBROSING ALVEOLITIS; LUNG; METHODOLOGY; OXIMETRY; PATHOPHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; TIME FACTOR; TREATMENT OUTCOME; UNITED KINGDOM; WALK TEST;

ACTIVITIES OF DAILY LIVING; AMBULATORY CARE; BIOMARKERS; CLINICAL PROTOCOLS; CROSS-OVER STUDIES; DYSPNEA; HEALTH STATUS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG DISEASES, INTERSTITIAL; OXIMETRY; OXYGEN; OXYGEN INHALATION THERAPY; PROSPECTIVE STUDIES; RESEARCH DESIGN; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; UNITED KINGDOM; WALK TEST;

EID: 85018296773     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-017-1912-9     Document Type: Article

References (32)

1. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir Med. 2005;99(4):408-14.
2. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-117.
3. Wells AU, Hansell DM, Rubens MB, Cailes JB, Black CM, du Bois RM. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison. Am J Respir Crit Care Med. 1997;155(5):1657-64.
4. Risk C, Epler GR, Gaensler EA. Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest. 1984;85(1):69-74.
5. Weitzenblum E, Ehrhart M, Rasaholinjanahary J, Hirth C. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration. 1983;44(2):118-27.
6. Charlie S, Highland KB. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med. 2005;11:452-5.
7. Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med. 2005;171:1150-7.
8. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, et al. Prognostic value of desaturation during a 6-minute Walk Test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168:1084-90.
9. Bye PT, Anderson SD, Woolcock AJ, Young IH, Alison JA. Bicycle endurance performance of patients with interstitial lung disease breathing air and oxygen. Am Rev Respir Dis. 1982;126(6):1005-12.
10. Visca D, Montgomery A, de Lauretis A, Sestini P, Soteriou H, Maher TM, et al. Ambulatory oxygen in interstitial lung disease. Eur Respir J. 2011;38(4):987-90.
11. Frank RC, Hicks S, Duck AM, Spencer L, Leonard CT, Barnett E. Ambulatory oxygen in idiopathic pulmonary fibrosis: of what benefit? Eur Respir J. 2012;40(1):269-70.
12. Nishiyama O, Miyajima H, Fukai Y, Yamazaki R, Satoh R, Yamagata T, et al. Effect of ambulatory oxygen on exertional dyspnoea in IPF patients without resting hypoxemia. Respir Med. 2013;107(8):1241-6.
13. Troy L, Young I, Munoz P, Taylor N, Webster S, Lau E, et al. Does supplemental oxygen increase exercise endurance in patients with idiopathic pulmonary fibrosis? Respirology. 2014;19:95.
14. Sharp C, Adamali H, Millar AB. Ambulatory and short-burst oxygen for interstitial lung disease. Cochrane Database Syst Rev. 2016;7, CD011716.
15. Hardinge M, Suntharalingam J, Wilkinson T, British Thoracic Society. Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults. Thorax. 2015;70(6):589-91.
16. Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, et al. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012;67(9):804-10.
17. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnoea measure: the UCSD shortness of breath questionnaire. Chest. 1998;113:619-24.
18. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407-15.
19. Jones PW, Quirk FH, Baverstock CM. The St. George's Respiratory Questionnaire. Resp Med. 1991;85(Suppl B):25-31.
20. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361-70.
21. Borg GA. Psychophysical basis of perceived exertion. Med Sci Sports Exerc. 1982;14:377-81.
22. Arnold E, Bruton A, Donovan-Hall M, Fenwick A, Dibb B, Walker E. Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study. BMC Pulm Med. 2011;11:9.
23. Patel AS, Siegert RJ, Keir GJ, Bajwah S, Barker RD, Maher TM, et al. The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease. Respir Med. 2013;107(9):1438-43.
24. Little RJ, D'Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, Neaton JD, Rotnitzky A, Scharfstein D, Shih WJ, Siegel JP, Stern H. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367(14):1355-60.
25. Hill K, Dolmage TE, Woon L, Goldstein R, Brooks D. Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease. Thorax. 2010;65(6):486-91.
26. Rabinovich RA, Louvaris Z, Raste Y, Langer D, Van Remoortel H, Giavedoni S, et al. PROactive Consortium. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J. 2013;42(5):1205-15.
27. Follick M, Ahem D, Laser-Wolston N. Evaluation of a daily activity diary for chronic pain patients. Pain. 1984;19:373-82.
28. Moore R, Berlowitz D, Denehy L, Jackson B, McDonald CF. Comparison of pedometer and activity diary for measurement of physical activity in chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2009;29(1):57-61.
29. Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. London: Sage Publications; 2006.
30. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, editors. Analyzing qualitative data. London: Routledge 1994. p. 173-94.
31. O'Cathain A, Murphy E, Nicholl J. Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study. BMC Health Serv Res. 2007;7:85.
32. Barbour RS. The case for combining qualitative and quantitative approaches in health and services research. J Health Serv Res Policy. 1999;4:39-43.